EDTUTC-4 New YorkLog in Sign up

LXEO
Lexeo Therapeutics, Inc. Common Stock
stockNASDAQ

Market OpenOct 5, 2026 10:47:25 AM EDT

3.56USD+0.850%(+0.03)401,990

3.5500Bid3.5600Ask0.0100Spread

LXEO News

Day breaks

05:56 AM EDTStifel reiterates Buy rating on Lexeo Therapeutics stock at $17 ·

Investing.com

09:00 AM EDTLexeo Therapeutics Announces Oral Presentation of LX2006 at the International Congress of Parkinson’s Disease and Movement Disorders 2026 (MDS) ·

GlobeNewswire Inc.

09:40 AM EDTLexeo Therapeutics at Stifel 2026 Virtual Cardiometabolic Forum: pipeline push ·

Investing.com

04:34 PM EDTLexeo Therapeutics completes acquisition of Mantle Therapeutics ·

Investing.com

08:00 AM EDTApertura Gene Therapy to Provide Lexeo Therapeutics Access to TfR1 CapX™ for Program Designed to Treat Friedreich Ataxia ·

PR Newswire

07:00 AM EDTLexeo Therapeutics to Participate in the Stifel 2026 Virtual Cardiometabolic Forum ·

GlobeNewswire Inc.

01:49 PM EDTLexeo Therapeutics, Inc. (LXEO) M&A Call Transcript ·

Seeking Alpha

10:30 AM EDTBaird reiterates Lexeo Therapeutics stock rating on acquisition deal ·

Investing.com

09:34 AM EDTWhy is Lexeo Therapeutics stock gaining today? ·

Investing.com

07:31 AM EDTLexeo Therapeutics Signs Series Of Strategic Transactions To Expand Presence In Friedreich Ataxia ·

RTTNews

07:00 AM EDTLexeo Therapeutics Enters Into Agreement to Acquire Mantle Therapeutics and Announces Multiple New Strategic Collaborations to Expand Leadership in Friedreich Ataxia ·

GlobeNewswire Inc.